The Women in Cancer Immunotherapy Network (WIN) is a Society for Immunotherapy of Cancer (SITC) initiative seeking to promote and elevate women in the cancer immunotherapy field. Championed by SITC Past President Lisa H. Butterfield, PhD, the society's first female president, WIN provides a forum for women to discuss important topics relevant to their advancement in the field.
SITC is excited to announce the 2022 WIN Leadership Institute to be held in-person on Aug. 1-2, 2022 in Seattle, WA. The program, free of charge to accepted applicants, is professional development and a networking event that seek to empower emerging female leaders in the cancer immunotherapy field.
2022 WIN Leadership Institute
This program features presentations from experienced female leaders, panel discussions allowing participants to ask questions and interact with these leaders and our distinguished program organizers, and virtual networking opportunities.
Applications were due March 2, 2022 at 5 p.m. PST.
Available to SITC members, the WIN is creating a database that can be used to better identify female experts to engage in society activities. The network is seeking women interested in presenting data, speaking at meetings, serving as subject matter experts, conducting article reviews for the Journal for ImmunoTherapy of Cancer (JITC), serving as meeting chairs, co-chairs, organizers, and more. Female SITC members are asked to sign up for this opportunity via the SITC Volunteer Pool to indicate your interest and be included in this database. SITC will use this information to better ensure balanced representation in all society activities. Please join now to be a part of this exciting effort within the society.If you have questions about the database, please contact Program Manager, Maggie Douglas
Applications were due 5 p.m. PST on March 2, 2022, the application site is now closed.
Share this opportunity with other women in your network.
If you have questions about this program, please contact the SITC Education team.
At SITC’s WIN Leadership Institute, our goal is to have a safe and meaningful in-person experience. We will be adhering to the local safety guidelines and regulations. For the latest information on requirements for Seattle, click here. In addition, SITC in-person meetings will have the following safety measures in place.
Proof of full vaccination for COVID-19 will be required for program attendees. SITC is currently exploring options for validating this information and will communicate that process when it is available.
SITC strongly recommends masks to be worn indoors for attendees.
SITC Professional Interest Communities are an original series of online communities created exclusively for SITC members. Within these communities, researchers and clinicians in the cancer immunotherapy field expand their network and receive career development support from colleagues.The Women in SITC Community is open to women who share a common interest in immunology and cancer. Open to professional women, the goal of the community is to increase females in leadership roles within the society, foster connections and working opportunities among members, discuss immunotherapy toxicities (open to other specialties that deal with toxicity of immunotherapy), create mentorship opportunities, discuss gender bias and professional opportunities and contributions to the field of oncology/immunotherapy.Not a member? Join SITC today and gain immediate access to the Women in SITC Community!
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org